Prostate cancer continues to be a major healthcare concern worldwide, creating an increasing demand for innovative oncology therapies. Apalutamide 60 mg Tablets, manufactured and exported by Cordium Pharmaceuticals Pvt Ltd, offer an advanced treatment option for patients diagnosed with specific stages of prostate cancer.
As a globally focused pharmaceutical company, Cordium Pharmaceuticals provides reliable access to high-quality oncology medicines for healthcare providers, distributors, hospitals, and importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.
What Are Apalutamide 60 mg Tablets?
Apalutamide is an oral androgen receptor inhibitor prescribed to manage certain types of prostate cancer by reducing the effects of male hormones that contribute to cancer growth.
It is commonly indicated for:
- Non-metastatic castration-resistant prostate cancer (nmCRPC)
- Metastatic castration-sensitive prostate cancer (mCSPC)
- Advanced prostate cancer treatment under specialist supervision
How Apalutamide Supports Prostate Cancer Treatment
Prostate cancer cells depend heavily on androgen hormones, including testosterone, for growth and survival.
Apalutamide works by:
✔ Blocking androgen receptors
✔ Reducing cancer cell stimulation
✔ Delaying disease progression
✔ Lowering the risk of metastasis
✔ Supporting long-term treatment outcomes
✔ Complementing androgen deprivation therapy (ADT)
Benefits of Apalutamide 60 mg Tablets
Precision Oncology Treatment
Targets androgen receptor pathways involved in prostate cancer progression.
Convenient Oral Dosage
Administered as tablets without invasive procedures.
Improved Disease Management
Helps delay the spread of cancer in eligible patients.
Physician-Guided Therapy
Integrated into personalized oncology treatment plans.
Quality-Assured Manufacturing
Produced under internationally recognized pharmaceutical standards.
Why Global Demand for Apalutamide Is Increasing
Healthcare systems across Africa, Asia, the Middle East, Europe, and North America are investing more heavily in advanced cancer therapies due to rising prostate cancer cases and aging populations.
Countries experiencing increasing demand include:
Africa
🇰🇪 Kenya
🇳🇬 Nigeria
🇬🇭 Ghana
🇿🇦 South Africa
Asia
🇵🇭 Philippines
🇻🇳 Vietnam
🇺🇿 Uzbekistan
🇰🇿 Kazakhstan
Middle East
🇦🇪 UAE
🇸🇦 Saudi Arabia
Western Markets
🇺🇸 USA
🇬🇧 UK
Recommended Administration
Important: Apalutamide should only be used under the supervision of a qualified oncologist.
General treatment protocols may include:
- Total prescribed daily dose as directed by the physician
- Can be taken with or without food
- Continue treatment consistently unless advised otherwise
- Do not stop medication without medical consultation
Individual treatment plans vary from patient to patient.
Possible Side Effects
Patients may experience:
- Tiredness or fatigue
- Skin rash
- High blood pressure
- Joint discomfort
- Weight loss
- Diarrhea
- Thyroid changes
- Increased risk of falls
Any unusual symptoms should be reported to a healthcare professional immediately.
Why Choose Cordium Pharmaceuticals Pvt Ltd?
Cordium Pharmaceuticals Pvt Ltd is committed to delivering trusted pharmaceutical solutions to international markets.
Our Global Strengths
✅ Dedicated Oncology Product Portfolio
✅ International Export Capabilities
✅ Stringent Quality Control Systems
✅ Reliable Supply Chain Management
✅ Competitive Pricing Structure
✅ Regulatory Documentation Support
✅ Timely Global Deliveries
✅ Customer-Centric Pharmaceutical Solutions
Industries We Support
We collaborate with:
- Pharmaceutical Importers
- Government Healthcare Agencies
- Oncology Hospitals
- Cancer Specialty Clinics
- Healthcare Procurement Companies
- International Distributors
- Pharmaceutical Wholesalers
- Medical Institutions
